Search
for

    Sort by

    Community Join

    990-1000 / 1000+ results

      community Low topical fin + 0.5% pyrilutamide

      in Research/Science  2 upvotes 2 months ago
      Using a combination of low-dose topical finasteride (0.025%) and 0.5% pyrilutamide for hair loss, with a focus on minimizing side effects. The user seeks experiences and results from others who have tried this combination.

      community Since there is so much hype for cosmeRNA and HMI-115...

      in Chat  46 upvotes 3 years ago
      Exploring different treatments for hair loss, such as cosmeRNA and HMI-115 which are small interference messenger RNA that inhibits the DHT receptor and an antibody that binds to the prolactin (PRL) receptor respectively; and researching mechanism and environment of hyperresponders.

      community My Daily Fight against the Norwood Reaper

      in Treatment  10 upvotes 1 year ago
      The conversation discusses hair loss treatments, specifically using Minoxidil, finasteride, and RU58841. Users suggest simplifying the application routine and question the absence of dutasteride.

      community gt20029 any u-lab order possible?

      in Product  8 upvotes 1 year ago
      The user is seeking alternative hair loss treatments due to side effects from finasteride and minoxidil. They are inquiring about the availability of gt20029 from u-lab.

      community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance

      in Research/Science  127 upvotes 2 years ago
      The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.

      community Breezula CB-03-01

      in Treatment  11 upvotes 6 years ago
      The conversation is about a potential new hair loss treatment called Breezula CB-03-01. Users are discussing updates on its development and sharing personal experiences with making or using it.